The Motley Fool·4d ago·Robert IzquierdoStanford Dumps $8.5M HeartFlow Stake: Profit-Taking or Red Flag?Stanford exits $8.5M HeartFlow stake via share sale. Despite exit, strong 40% YoY growth suggests profit-taking over fundamental concerns. GOOGGOOGLHTFLrevenue growthSEC filing
Benzinga·Mar 27·Usa News GroupFive AI Leaders Transform Cardiac Diagnostics, Expanding Access to Remote CommunitiesFive AI companies advance decentralized cardiac diagnostics through partnerships expanding access to remote communities and strengthening clinical evidence bases. GEHCHTFLBEATBEATWHYPR+1clinical validationcardiovascular disease
The Motley Fool·Mar 25·Jonathan PoncianoHeartFlow CMO Sells $1.66M in Stock; Company Eyes Path to ProfitabilityHeartFlow CMO Rogers Campbell sold $1.66M in shares via pre-arranged plan while company guides 2026 revenue to $218–$222M, maintaining strong growth momentum despite current unprofitability. HTFLrevenue growthinsider trading